Wei L - Search Results

1

Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer.

Shukla S, Patel H, Chen S, Sun R, Wei L, Chen ZS. Shukla S, et al. Among authors: wei l. Cancer Pathog Ther. 2023 Oct 18;2(3):135-141. doi: 10.1016/j.cpt.2023.10.003. eCollection 2024 Jul. Cancer Pathog Ther. 2023. PMID: 39027143 Free PMC article. Review.

2

Darovasertib, a novel treatment for metastatic uveal melanoma.

Cao L, Chen S, Sun R, Ashby CR Jr, Wei L, Huang Z, Chen ZS. Cao L, et al. Among authors: wei l. Front Pharmacol. 2023 Jul 28;14:1232787. doi: 10.3389/fphar.2023.1232787. eCollection 2023. Front Pharmacol. 2023. PMID: 37576814 Free PMC article. Review.

3

Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A.

Xu Y, Wang Z, Zhang L, Gao C, Li F, Li X, Ke Y, Liu HM, Hu Z, Wei L, Chen ZS. Xu Y, et al. Among authors: wei l. J Cancer. 2023 May 5;14(7):1182-1194. doi: 10.7150/jca.83219. eCollection 2023. J Cancer. 2023. PMID: 37215441 Free PMC article.

4

Glutathione-Sensitive Photosensitizer-Drug Conjugates Target the Mitochondria to Overcome Multi-Drug Resistance in Cancer.

Song W, Yang H, Wang Y, Chen S, Zhong W, Wang Q, Ding W, Xu G, Meng C, Liang Y, Chen ZS, Cao S, Wei L, Li F. Song W, et al. Among authors: wei l. Adv Sci (Weinh). 2024 Aug;11(30):e2307765. doi: 10.1002/advs.202307765. Epub 2024 Jun 19. Adv Sci (Weinh). 2024. PMID: 38898730 Free PMC article.

5

Research progress in overcoming ibrutinib drug resistance.

Ma XY, Zhao M, Li YD, Chen Y, Wei L, Chen ZS. Ma XY, et al. Among authors: wei l. Drugs Today (Barc). 2022 Feb;58(2):85-94. doi: 10.1358/dot.2022.58.2.3360405. Drugs Today (Barc). 2022. PMID: 35188143

6

PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

Gupta P, Kathawala RJ, Wei L, Wang F, Wang X, Druker BJ, Fu LW, Chen ZS. Gupta P, et al. Among authors: wei l. Cancer Lett. 2016 Dec 28;383(2):220-229. doi: 10.1016/j.canlet.2016.09.025. Epub 2016 Oct 5. Cancer Lett. 2016. PMID: 27720778

7

Modulating ROS to overcome multidrug resistance in cancer.

Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR Jr, Yang DH, Chen ZS. Cui Q, et al. Among authors: wei l. Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14. Drug Resist Updat. 2018. PMID: 30471641 Review.

8

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.

Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, Huang JJ, Ashby CR Jr, Chen ZS. Narayanan S, et al. Among authors: wei l. Drug Resist Updat. 2020 Jan;48:100663. doi: 10.1016/j.drup.2019.100663. Epub 2019 Nov 11. Drug Resist Updat. 2020. PMID: 31785545 Review.

9

Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic Bacteria.

Kong J, Wu ZX, Wei L, Chen ZS, Yoganathan S. Kong J, et al. Among authors: wei l. Front Microbiol. 2020 Jul 29;11:1718. doi: 10.3389/fmicb.2020.01718. eCollection 2020. Front Microbiol. 2020. PMID: 32849365 Free PMC article.

10

Recent progress on targeting leukemia stem cells.

Ma XY, Wei L, Lei Z, Chen Y, Ding Z, Chen ZS. Ma XY, et al. Among authors: wei l. Drug Discov Today. 2021 Aug;26(8):1904-1913. doi: 10.1016/j.drudis.2021.05.009. Epub 2021 May 23. Drug Discov Today. 2021. PMID: 34029689 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,041 results

Search Page

Filters